Please assess the completion status of the following clinical trial:

Trial Title: In Vivo Patient Preoperative Skin Prep Persistence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects of any race~* Subjects in good general health~* Minimum skin flora baseline requirements on abdomen and groin~Exclusion Criteria:~* Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test areas~* Topical antimicrobial exposure within 14 days prior to screening and treatment days~* Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 3M CHG/IPA - Abdominal Region (Type: EXPERIMENTAL): Apply Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% for 30 seconds and allow to dry for 3 minutes.
- Normal Saline - Abdominal Region (Type: PLACEBO_COMPARATOR): Apply 0.9% sodium chloride with applicator for 30 seconds and allow to dry for 3 minutes.
- 3M CHG/IPA - Inguinal Region (Type: EXPERIMENTAL): Apply Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% for 30 seconds and allow to dry for 3 minutes.
- Normal Saline - Inguinal Region (Type: PLACEBO_COMPARATOR): Apply 0.9% sodium chloride with applicator for 30 seconds and allow to dry for 3 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).